Project Grant R01MH137219

Award Date 9/1/24
Completion Date 5/31/29
Dollars Obligated $1.6M
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90024, USA
Similar Awards
This Project Grant award from the National Institute of Mental Health (NIMH), under CFDA 93.242 Mental Health Research Grants, is for a collaborative research project titled "PSYCHEMERGE: ADVANCING PRECISION PSYCHIATRY." The $984,036 award will be used to extend the foundational efforts of the PSYCHEMERGE network to address barriers to scalability, utility of genomic data, clinical application, and translation to clinical practice in a precision psychiatry paradigm. The key aims of the...
The National Institute of Mental Health (NIMH) awarded a $1,613,367 Project Grant under the Mental Health Research Grants (CFDA 93.242) program to Geisinger Clinic in Danville, PA. The grant, titled "7/7-PSYCHEMERGE: ADVANCING PRECISION PSYCHIATRY", aims to address barriers to scalability, utility of genomic data, clinical application, and translation to clinical practice in a precision psychiatry paradigm. Specifically, the grant will create a nationwide federated transfer-learning...
The National Institute of Mental Health (NIMH) awarded a $1,635,902 Project Grant (CFDA 93.242 - Mental Health Research Grants) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to advance precision psychiatry research. The 5-year project, titled "PSYCHEMERGE: Advancing Precision Psychiatry," aims to: Create a nationwide federated transfer-learning platform for developing generalizable and bias-aware algorithms; Integrate state-of-the-art...
The National Institute of Mental Health (NIMH) awarded a 5-year $878,464 Project Grant (CFDA 93.242 Mental Health Research Grants) to Mayo Clinic, a renowned academic medical center, to advance precision psychiatry research. The key objectives are to: Create a nationwide federated transfer-learning platform for developing generalizable and bias-aware algorithms. Integrate state-of-the-art methods for inclusive trans-ancestry genomic analysis and leverage medical record data to discover novel...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $1,919,498.00 to The Research Foundation For The State University Of New York, doing business as SUNY Downstate Health Sciences University, to advance precision psychiatry research. The project, titled "PSYCHEMERGE: ADVANCING PRECISION PSYCHIATRY," aims to develop a nationwide federated transfer-learning platform for generalizable...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $779,000 to the University of Chicago to leverage electronic health records, dimensional phenotyping, and genetic analyses to develop machine learning-based predictive models and identify subtypes of clinical outcomes among individuals with schizophrenia. The award aims to advance the goals of precision psychiatry by enabling individualized...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $961,668 to The Feinstein Institutes for Medical Research to leverage electronic health records, dimensional phenotyping, and genetic analyses to build predictive models and identify subtypes of clinical outcomes for individuals with schizophrenia and other psychosis-related disorders. The 5-year project aims to advance precision psychiatry by...
The National Institute of Mental Health awarded a three-year Project Grant totaling $3,618,976 to the University of California, Los Angeles under the Mental Health Research Grants program (CFDA 93.242) to develop in situ single-cell multi-omic and morphological profiling methods for mammalian brains. Specifically, the university will work to design photonic-indexing sequencing strategies to spatially barcode tissue with single-cell resolution, integrating techniques such as PI-ATAC-seq and...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), is focused on leveraging electronic health records (EHRs) and genetic data to develop predictive models and identify subtypes of psychosis-related disorders. The key products and services to be delivered under this $1,424,534 award include: Building machine learning-based prediction models to forecast clinical outcomes such as treatment response, illness...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $720,375 to New York University School of Medicine to leverage electronic health records (EHRs) and advanced data analytics to develop predictive models and identify clinical outcome subtypes for psychosis-related disorders. The key products and services to be delivered include: Building machine learning models to forecast major prognostic outcomes...

The National Institute of Mental Health (NIMH) awarded a $1,564,542 Project Grant under the Mental Health Research Grants (CFDA 93.242) program to the University of California, Los Angeles (UCLA) for the "PSYCHEMERGE: ADVANCING PRECISION PSYCHIATRY" project. The 5-year grant, effective September 1, 2024, aims to address barriers to scalability, utility of genomic data, clinical application, and translation to clinical practice in a precision psychiatry paradigm. Key objectives include creating a nationwide federated transfer-learning platform, performing inclusive trans-ancestry genomic analysis, and assessing the feasibility, utility, and attitudes towards precision psychiatry tools. With a combined sample of over 29 million clinical EHR records and nearly 2 million genetic datasets across 12 diverse sites, the project represents a major step towards equitable precision psychiatry and aligns with the NIMH's strategic plan.

Generated 8/5/25, 2:45 AM